Russ Abney

Russ Abney

Russ Abney is a partner in Ferrer, Poirot & Wansbrough’s pharmaceutical litigation section. He received his bachelor’s degree from University of California, Berkeley and went on to graduate cum laudewith a Juris Doctor from University of Georgia School of Law.

After leaving a Texas defense law firm in 1998, Russ began working with medical and scientific experts to help people injured by dangerous drugs and defective medical devices. His work has benefited injury victims in a variety of high-profile multidistrict litigation (MDL) cases, including:

  • Fen-Phen
  • Fosamax®
  • Hormone replacement therapy
  • Lipitor®
  • Meridia®
  • Permax®
  • Rezulin
  • Shoulder pain pumps
  • Talc
  • Vioxx®
  • Xarelto®

Russ is licensed to practice law in Alabama, Georgia, New York, and Texas. He is a member of the American Association for Justice, Georgia Trial Lawyers Association, and Texas Trial Lawyers Association. Russ also serves on the board of directors of Making the Grade, an organization that helps young people in Ethiopia obtain excellent educations.

Appointed to Xarelto® Plaintiffs’ Steering Committee

In March 2015, Russ Abney was appointed to the Plaintiffs’ Steering Committee for the Xarelto® MDL in Louisiana. Nearly two dozen Xarelto® lawsuits were consolidated in December 2014, and Russ was selected to advocate on behalf of multiple Xarelto®injury vicitims from across the country.

There is still time to make a Xarelto® injury claim, but time is running out. Contact us immediately if you or a loved one were injured by Xarelto® and need legal help.